This content is intended for Healthcare Professionals only.
It is a source of continuing educational content for you and your patients. You must not use the content for any other purpose. By clicking ‘yes’ below you are agreeing that you are a registered dental healthcare professional with a current license number and are entitled to access this content. Your use of this content is also subject to our “Terms of Use” and “Privacy Policy”.
Comparative Effects of 2 Chemotherapeutic Mouthrinses
on the Development of Supragingival Dental Plaque and Gingivitis
Conclusion
LISTERINE® Antiseptic produces gingivitis reductions comparable to Peridex™ at 6 months (including gingivitis in posterior regions).
Comparative Effects of 2 Chemotherapeutic Mouthrinses on the Development of Supragingival Dental Plaque and Gingivitis1,2
- Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579.
Peridex™ vs LISTERINE® for Gingivitis and Dental Plaque
Objective
Determine the efficacy of 2 mouthrinses - LISTERINE® Antiseptic and Peridex™ - used as supplements to regular oral hygiene measures in reducing supragingival dental plaque and gingivitis (N=124).
Methodology
Double-blind, controlled, parallel design clinical study of healthy male and female subjects (aged ≥21 years) with preexisting plaque and gingivitis but without evidence of periodontitis.
overholsermethodology.png
Results
At 6 months, gingivitis development was inhibited by 35.9% in the LISTERINE® Antiseptic group and by 30.5% in the Peridex™ group, when compared to the hydroalcohol control (P<0.001).
At 6 months, gingivitis development—in posterior regions—was inhibited by 33.2% and 34.4% in the LISTERINE® Antiseptic group and by 26.6% and 33.8% in the Peridex™ group, when compared to the hydroalcohol control (P<0.001).2
clinical_evidence_article_8.jpg
Conclusion
LISTERINE® Antiseptic produces gingivitis reductions comparable to Peridex™ at 6 months (including gingivitis in posterior regions).
†During the study, subjects followed their usual oral hygiene and dietary habits.
References: 1. Overholser CD, Meiller TF, DePaola LG, Minah GE, Niehaus C. Comparative effects of 2 chemotherapeutic mouthrinses on the development of supragingival dental plaque and gingivitis. J Clin Periodontol. 1990;17:575-579. 2. Data on file, Johnson & Johnson Consumer Inc.
For Dental Healthcare Professionals Only. For Educational Purposes Only.
Featured Product in this Article:
